Ceruloplasmin and the Extent of Heart Failure in Ischemic and Nonischemic Cardiomyopathy Patients
Objective. Ceruloplasmin was elevated in patients with coronary heart disease, but the relationship between ceruloplasmin and heart failure was still unknown. We aimed to evaluate ceruloplasmin in heart failure patients and assess association between ceruloplasmin and the extent of heart failure. Me...
Saved in:
Main Authors: | Yifei Xu, Haiyan Lin, Ying Zhou, Gang Cheng, Geng Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2013/348145 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bevacizumab: A Rare Cause of Nonischemic Cardiomyopathy
by: Oreoluwa Oladiran, et al.
Published: (2018-01-01) -
Neopterin and Beta-2 Microglobulin Relations to Immunity and Inflammatory Status in Nonischemic Dilated Cardiomyopathy Patients
by: Celina Wojciechowska, et al.
Published: (2014-01-01) -
MODERN APPROACHES TO THE DIAGNOSIS AND TREATMENT OF NONISCHEMIC (ARTERIAL) PRIAPISM
by: S. K. Yarovoi, et al.
Published: (2017-12-01) -
Elevated resting heart rate in adolescent men and risk of heart failure and cardiomyopathy
by: Martin Lindgren, et al.
Published: (2020-06-01) -
Impairment of myocardial perfusion correlates with heart failure severity in patients with non‐compaction cardiomyopathy
by: Andraz Cerar, et al.
Published: (2020-06-01)